Ono Pharmaceutical Co., Ltd. (OPHLY)
OTCMKTS · Delayed Price · Currency is USD
3.700
+0.040 (1.09%)
Jul 16, 2025, 4:00 PM EDT
Ono Pharmaceutical Employees
Ono Pharmaceutical had 4,287 employees as of March 31, 2025. The number of employees increased by 434 or 11.26% compared to the previous year.
Employees
4,287
Change (1Y)
434
Growth (1Y)
11.26%
Revenue / Employee
$758,402
Profits / Employee
$77,959
Market Cap
5.29B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Ono Pharmaceutical News
- 24 days ago - Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea - Seeking Alpha
- 24 days ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Benzinga
- 24 days ago - Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea - Business Wire
- 2 months ago - Ono Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Ono Pharmaceutical reports FY results - Seeking Alpha
- 3 months ago - What's Going On With Cue Biopharma Shares Tuesday? - Benzinga
- 4 months ago - Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal - Benzinga
- 4 months ago - Ionis out licenses blood disorder therapy to Ono in a deal worth up to $940M - Seeking Alpha